# Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis

> **NCT07318129** · NA · RECRUITING · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 220 (estimated)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis (RRMS)

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Indole-3-propionic acid (IPA)

## Key facts

- **NCT ID:** NCT07318129
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2028-07-15
- **Final completion:** 2028-07-15
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318129, "Indole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07318129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*